Related Experiment Video
Updated: Mar 18, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
A previously unrecognized role of C3a in proteinuric progressive nephropathy
Marina Morigi1, Monica Locatelli1, Cinzia Rota1
1IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.
Abstract:
Podocyte loss is the initial event in the development of glomerulosclerosis, the structural hallmark of progressive proteinuric nephropathies. Understanding mechanisms underlying glomerular injury is the key challenge for identifying novel therapeutic targets. In mice with protein-overload induced by bovine serum albumin (BSA), we evaluated whether the alternative pathway (AP) of complement mediated podocyte depletion and podocyte-dependent parietal epithelial cell (PEC) activation causing glomerulosclerosis. Factor H (Cfh(-/-)) or factor B-deficient mice were studied in comparison with wild-type (WT) littermates. WT+BSA mice showed podocyte depletion accompanied by glomerular complement C3 and C3a deposits, PEC migration to capillary tuft, proliferation, and glomerulosclerosis. These changes were more prominent in Cfh(-/-) +BSA mice. The pathogenic role of AP was documented by data that factor B deficiency preserved glomerular integrity. In protein-overload mice, PEC dysregulation was associated with upregulation of CXCR4 and GDNF/c-Ret axis. In vitro studies provided additional evidence of a direct action of C3a on proliferation and CXCR4-related migration of PECs. These effects were enhanced by podocyte-derived GDNF. In patients with proteinuric nephropathy, glomerular C3/C3a paralleled PEC activation, CXCR4 and GDNF upregulation. These results indicate that mechanistically uncontrolled AP complement activation is not dispensable for podocyte-dependent PEC activation resulting in glomerulosclerosis.
Insights
Uncontrolled complement alternative pathway (AP) activation drives podocyte loss and parietal epithelial cell (PEC) activation, leading to glomerulosclerosis in proteinuric kidney diseases.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Podocyte loss initiates glomerulosclerosis, a key feature of proteinuric nephropathies.
- Understanding glomerular injury mechanisms is crucial for developing new therapeutic targets.
Purpose of the Study:
- To investigate if the complement alternative pathway (AP) mediates podocyte depletion and parietal epithelial cell (PEC) activation in protein-overload-induced glomerulosclerosis.
- To explore the role of C3a, CXCR4, and GDNF/c-Ret signaling in this process.
Main Methods:
- Utilized mice deficient in Factor H or Factor B, alongside wild-type littermates, subjected to bovine serum albumin (BSA)-induced protein overload.
- Conducted in vitro studies using PECs and analyzed patient samples from proteinuric nephropathy cases.
Main Results:
- BSA-induced protein overload caused podocyte depletion, PEC activation, and glomerulosclerosis in wild-type mice, exacerbated in Factor H-deficient mice.
- Factor B deficiency protected against glomerular injury, confirming the pathogenic role of the AP.
- Complement component C3a directly promoted PEC proliferation and migration, an effect amplified by podocyte-derived GDNF via the c-Ret axis.
- Glomerular C3/C3a, PEC activation, CXCR4, and GDNF were upregulated in both mouse models and human proteinuric nephropathy patients.
Conclusions:
- Uncontrolled activation of the complement alternative pathway is essential for podocyte-dependent PEC activation and subsequent glomerulosclerosis.
- Targeting the AP, C3a, or the GDNF/c-Ret/CXCR4 axis may offer novel therapeutic strategies for proteinuric kidney diseases.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction